Literature DB >> 9249146

Glycosylation of alpha1-acid glycoprotein in inflammatory disease: analysis by high-pH anion-exchange chromatography and concanavalin A crossed affinity immunoelectrophoresis.

I Rydén1, G Skude, A Lundblad, P Påhlsson.   

Abstract

High-pH anion-exchange chromatography with pulsed amperometric detection is a highly sensitive technique that can be used for detecting changes in sialylation and fucosylation, as well as different branching patterns of N-linked oligosaccharides in glycoproteins. We examined the N-glycans of alpha1-acid glycoprotein obtained from twelve patients with various inflammatory conditions with this technique, as well as traditional concanavalin A crossed affinity immunoelectrophoresis. We found the chromatographic profiles of N-glycans in all patients with rheumatoid arthritis to be very similar, but significantly different from normal controls. N-glycans from patients with ulcerative colitis also showed specific alterations in their chromatographic profiles. However, some heterogeneity was found between these patients, perhaps reflecting changes in glycosylation secondary to certain states of the disease, or to medical treatment. We conclude that this technique is useful for detailed mapping of glycosylation changes in alpha1-acid glycoprotein in clinical samples, and that it may be used to further increase our knowledge about glycosylation changes in response to inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249146     DOI: 10.1023/a:1018503602681

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  21 in total

1.  Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels.

Authors:  O Pos; M E van der Stelt; G J Wolbink; M W Nijsten; G L van der Tempel; W van Dijk
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography.

Authors:  T C Bog-Hansen
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

3.  Microheterogeneity of the carbohydrate moiety of human alpha 1-acid glycoprotein in two benign liver diseases: alcoholic cirrhosis and acute hepatitis.

Authors:  D Biou; P Chanton; D Konan; N Seta; H N'Guyen; J Feger; G Durand
Journal:  Clin Chim Acta       Date:  1989-12-29       Impact factor: 3.786

4.  Studies of the sialylation and microheterogeneity of human serum alpha 1-acid glycoprotein in health and disease.

Authors:  S K Moule; M Peak; S Thompson; G A Turner
Journal:  Clin Chim Acta       Date:  1987-07-15       Impact factor: 3.786

5.  Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption.

Authors:  E Landberg; P Påhlsson; A Lundblad; A Arnetorp; J O Jeppsson
Journal:  Biochem Biophys Res Commun       Date:  1995-05-16       Impact factor: 3.575

6.  Changes in alpha 1-acid glycoprotein serum concentrations and glycoforms in the developing human fetus.

Authors:  N Seta; B Tissot; F Forestier; J Feger; F Daffos; G Durand
Journal:  Clin Chim Acta       Date:  1991-12-16       Impact factor: 3.786

7.  Glycan microheterogeneity of alpha 1-acid glycoprotein in sera and dialysates of patients on continuous ambulatory peritoneal dialysis.

Authors:  N H Fraeyman; E J Van de Velde; F M Belpaire; N H Lameire
Journal:  Clin Chim Acta       Date:  1989-04-28       Impact factor: 3.786

8.  Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.

Authors:  T W De Graaf; E C Van Ommen; M E Van der Stelt; P J Kerstens; A M Boerbooms; W Van Dijk
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  The mapping by high-pH anion-exchange chromatography with pulsed amperometric detection and capillary electrophoresis of the carbohydrate moieties of human plasma alpha 1-acid glycoprotein.

Authors:  P Hermentin; R Witzel; R Doenges; R Bauer; H Haupt; T Patel; R B Parekh; D Brazel
Journal:  Anal Biochem       Date:  1992-11-01       Impact factor: 3.365

10.  Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.

Authors:  T W De Graaf; M E Van der Stelt; M G Anbergen; W van Dijk
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  5 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

2.  Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes.

Authors:  Peter Gunnarsson; Louise Fornander; Peter Påhlsson; Magnus Grenegård
Journal:  Inflamm Res       Date:  2009-08-11       Impact factor: 4.575

3.  Microheterogeneity of acute phase proteins in patients with ulcerative colitis.

Authors:  Marian Grzymisławski; Katarzyna Derc; Magdalena Sobieska; Krzysztof Wiktorowicz
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

4.  Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease.

Authors:  M T Goodarzi; G A Turner
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

5.  Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein.

Authors:  Takayuki Asao; Shin Yazawa; Toyo Nishimura; Takashi Hayashi; Hideyuki Shimaoka; Abby R Saniabadi; Hiroyuki Kuwano
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.